| Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with … JL Descourouez, MR Jorgenson, JE Wergin, WE Rose Antimicrobial agents and chemotherapy 57 (3), 1518-1520, 2013 | 73 | 2013 |
| White paper on antimicrobial stewardship in solid organ transplant recipients M So, J Hand, G Forrest, SM Pouch, H Te, MI Ardura, RM Bartash, ... American journal of transplantation 22 (1), 96-112, 2022 | 47 | 2022 |
| Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus MR Jorgenson, DD DePestel, PL Carver Annals of Pharmacotherapy 45 (11), 1384-1398, 2011 | 39 | 2011 |
| Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients LE Splinter, L Kerstenetzky, MR Jorgenson, JL Descourouez, ... Annals of Pharmacotherapy 52 (2), 113-119, 2018 | 34 | 2018 |
| Ganciclovir‐resistant cytomegalovirus infection in abdominal solid organ transplant recipients: case series and review of the literature KE Rolling, MR Jorgenson, JL Descourouez, DA Mandelbrot, RR Redfield, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (10 …, 2017 | 29 | 2017 |
| Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes MR Jorgenson, JL Descourouez, B Cardinale, B Lyu, BC Astor, N Garg, ... Transplant Infectious Disease 21 (3), e13080, 2019 | 23 | 2019 |
| The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success F Aziz, MR Jorgenson, N Garg, M Mohamed, A Djamali, D Mandelbrot, ... Transplantation Reviews 34 (4), 100567, 2020 | 22 | 2020 |
| The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipients MR Jorgenson, JL Descourouez, LT Schulz, KA Goldrosen, JP Rice, ... Infection Control & Hospital Epidemiology 41 (9), 1068-1074, 2020 | 21 | 2020 |
| Cytomegalovirus antiviral stewardship in solid organ transplant recipients: a new gold standard MR Jorgenson, JL Descourouez, H Kleiboeker, K Goldrosen, L Schulz, ... Transplant Infectious Disease 24 (5), e13864, 2022 | 18 | 2022 |
| Fungal infections in liver transplant recipients M Scolarici, M Jorgenson, C Saddler, J Smith Journal of Fungi 7 (7), 524, 2021 | 18 | 2021 |
| Efficacy and safety of probiotics and synbiotics in liver transplantation MR Jorgenson, JL Descourouez, M Siodlak, S Tjugum, JP Rice, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (7 …, 2018 | 18 | 2018 |
| Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk … N Garg, M Jorgenson, J Descourouez, CM Saddler, S Parajuli, BC Astor, ... BMC nephrology 19, 1-7, 2018 | 17 | 2018 |
| The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients MR Jorgenson, JL Descourouez, B Lyu, BC Astor, N Garg, JA Smith, ... Clinical transplantation 33 (8), e13636, 2019 | 16 | 2019 |
| Clinically significant drug interaction between clotrimazole and tacrolimus in pancreas transplant recipients and associated risk of allograft rejection CW Viesselmann, JL Descourouez, MR Jorgenson, NA Radke, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (3 …, 2016 | 15 | 2016 |
| Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus … MR Jorgenson, H Kleiboeker, N Garg, S Parajuli, DA Mandelbrot, ... Transplant Infectious Disease 24 (1), e13766, 2022 | 14 | 2022 |
| The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients MR Jorgenson, JL Descourouez, N Garg, S Parajuli, DA Mandelbrot, ... Transplant Infectious Disease 23 (4), e13693, 2021 | 13 | 2021 |
| Outcomes of delayed graft function in kidney transplant recipients stratified by histologic biopsy findings S Rolak, A Djamali, DA Mandelbrot, BL Muth, MR Jorgenson, W Zhong, ... Transplantation Proceedings 53 (5), 1462-1469, 2021 | 12 | 2021 |
| Proton pump inhibitors, but not H2-receptor antagonists, are associated with incident fractures among kidney transplant recipients B Lyu, MR Jorgenson, KE Hansen, A Djamali, BC Astor Transplantation 104 (12), 2609-2615, 2020 | 11 | 2020 |
| Cytomegalovirus antiviral stewardship in the COVID‐19 era: increasing complexity of prophylaxis and treatment and potential mitigation strategies MR Jorgenson, JL Descourouez, C Wong, JR Strayer, S Parajuli, JP Rice, ... Transplant Infectious Disease 23 (4), e13586, 2021 | 10 | 2021 |
| Role of virus-specific T cell therapy for cytomegalovirus and BK infections in kidney transplant recipients S Parajuli, M Jorgenson, RO Meyers, A Djamali, J Galipeau Kidney360 2 (5), 905-915, 2021 | 10 | 2021 |
